The Crown Princess of Norway, Mette-Marit, has undergone a lung transplant at the Oslo University Hospital, a procedure that has drawn on British medical expertise. The palace confirmed the surgery on Wednesday, stating that the princess, 49, is recovering well. The operation was necessitated by her long-standing battle with pulmonary fibrosis, a condition that causes scarring of the lungs.
British medical teams have been acknowledged for their role in the procedure. Specialists from the Royal Brompton Hospital in London, a centre of excellence for respiratory medicine, were involved in the pre-operative assessment and the surgical planning. This collaboration underscores the reputation of British healthcare professionals in complex transplant surgeries.
Princess Mette-Marit was diagnosed with pulmonary fibrosis in 2018, a condition she has managed with medication and regular check-ups. The disease had progressed to a point where a transplant became the only viable option. The surgery lasted several hours and was conducted by a multinational team of surgeons, anaesthetists, and nurses.
Norwegian health officials praised the cross-border cooperation. 'This is a testament to the strength of international collaboration in medicine,' said Dr. Anne Grethe Myrseth, the hospital’s chief of thoracic surgery. 'We are grateful for the support from our British colleagues.'
The Royal Brompton Hospital is part of the Guy's and St Thomas' NHS Foundation Trust, known for its pioneering work in lung transplantation. The trust’s CEO, Dr. Ian Abbs, expressed pride in the contribution. 'Our teams are committed to sharing knowledge and skills worldwide. We wish the Crown Princess a speedy recovery.'
News of the transplant has dominated headlines in Norway, where the royal family is widely popular. King Harald and Queen Sonja visited their daughter-in-law after the procedure. Prime Minister Jonas Gahr Støre said, 'The entire nation is holding its breath and sending its best wishes.'
Crown Princess Mette-Marit, married to Crown Prince Haakon, is known for her work on public health issues, particularly HIV/AIDS and mental health. Her openness about her condition has been praised. In a previous interview, she spoke of the fear and uncertainty of living with a chronic illness. 'It feels like being locked in a cage, but you cannot see the bars,' she said.
Lung transplants carry significant risks, including rejection and infection. However, advances in immunosuppressive drugs and surgical techniques have improved outcomes. The princess will remain in hospital for several weeks and face months of rehabilitation.
The British medical community has a long history of involvement in high-profile transplant cases. In 2020, a team from London assisted in a heart transplant for a child in Egypt. The cross-border work is often done quietly, but the palace’s acknowledgment shines a light on this often unseen collaboration.
For many in Norway, the news is a reminder of the value of international expertise. The cost of the transplant is covered by the state healthcare system, but the involvement of foreign specialists has sparked discussion about the sharing of resources. Health Minister Bent Høie said, 'It is not about money. It is about saving lives and ensuring our citizens receive the best care possible.'
The Crown Princess’s condition had been stable until recently. She was forced to cancel public engagements late last year as her health deteriorated. The palace had requested privacy, but the seriousness of the situation became evident when she was admitted to hospital in December.
The operation has also drawn attention to the issue of organ donation. Norway has a relatively high rate of donated organs, but there is always a shortage. The princess’s transplant was made possible by the generosity of an anonymous donor and their family. The palace expressed deep gratitude, asking the media to respect their privacy.
As the Crown Princess begins her recovery, the focus will be on the meticulous post-operative care. The team at Oslo University Hospital will be working in close contact with the London specialists. Updates on her condition are expected in the coming days.
The timing of the announcement, just weeks before the anniversary of King Harald’s accession to the throne, adds a layer of national significance. The royal family has faced health challenges before. The King himself underwent heart surgery in 2020.
For now, the mood in Norway is one of cautious optimism. Outside the hospital, well-wishers have left flowers and messages of support. 'She is not just a princess. She is a fighter,' said one woman, holding a bouquet of roses.
In London, the Royal Brompton team continues their daily work. A spokesperson said, 'We are pleased to have played a part in something so meaningful. Our thoughts are with the Crown Princess and her family.'
